Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.88

-1.2%

Dec 22 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Abuckatatime who wrote (9943)	10/21/1997 6:16:00 PM
From: Henry Niman	Read Replies (1) of 32384

Greg,I have to do some revisions myself because of the ALRI deal as well as the diabetes deal. Here's a quick outline which probably requires some revision. The next big clinical piece should be the pivotal Phase III topical Panretin data for KS. This North American study is essentially the same as the halted International study (except it does contain an interim look at the innitail patients, but did have a placebo check which indicated that the placebo response was less than 10%, as expected). Data may not be quite as dramatic as International, but it should meet the minimum delta requirement of 15% and make approval a slam dunk. This should come out this quarter with a NDA filed within 2-3 months after unblinding. I'll add much more later, but have to go check out more playoff games.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next